Correction to: Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors (Nature Biotechnology, (2008), 26, 4, (453-461), 10.1038/nbt1395)

Johannes L. Zakrzewski; David Suh; John C. Markley; Odette M. Smith; Christopher King; Gabrielle L. Goldberg; Robert Jenq; Amanda M. Holland; Jeremy Grubin; Javier Cabrera-Perez; Renier J. Brentjens; Sydney X. Lu; Gabrielle Rizzuto; Derek B. Sant’Angelo; Isabelle Riviere; Michel Sadelain; Glenn Heller; Juan Carlos Zúñiga-Pflücker; Chen Lu; Marcel R.M. van den Brink

doi:10.1038/s41587-024-02205-3

Correction to: Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors (Nature Biotechnology, (2008), 26, 4, (453-461), 10.1038/nbt1395)

Johannes L. Zakrzewski, David Suh, John C. Markley, Odette M. Smith, Christopher King, Gabrielle L. Goldberg, Robert Jenq, Amanda M. Holland, Jeremy Grubin, Javier Cabrera-Perez, Renier J. Brentjens, Sydney X. Lu, Gabrielle Rizzuto, Derek B. Sant’Angelo, Isabelle Riviere, Michel Sadelain, Glenn Heller, Juan Carlos Zúñiga-Pflücker, Chen Lu, Marcel R.M. van den Brink

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Correction to: Nature Biotechnologyhttps://doi.org/10.1038/nbt1395, published online 30 March 2008. In the version of the article initially published, Supplementary Fig. 10 included duplicated images in the row for day 11. As original data could not be located, a revised Supplementary Fig. 10 is shown in the Supplementary Information accompanying this amendment, with the day 11 row removed.

Original language	English (US)
Pages (from-to)	674
Number of pages	1
Journal	Nature biotechnology
Volume	42
Issue number	4
DOIs	https://doi.org/10.1038/s41587-024-02205-3
State	Published - Apr 2024
Externally published	Yes

All Science Journal Classification (ASJC) codes

Biotechnology
Bioengineering
Applied Microbiology and Biotechnology
Molecular Medicine
Biomedical Engineering

Access to Document

10.1038/s41587-024-02205-3

Cite this

Zakrzewski, J. L., Suh, D., Markley, J. C., Smith, O. M., King, C., Goldberg, G. L., Jenq, R., Holland, A. M., Grubin, J., Cabrera-Perez, J., Brentjens, R. J., Lu, S. X., Rizzuto, G., Sant’Angelo, D. B., Riviere, I., Sadelain, M., Heller, G., Zúñiga-Pflücker, J. C., Lu, C., & van den Brink, M. R. M. (2024). Correction to: Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors (Nature Biotechnology, (2008), 26, 4, (453-461), 10.1038/nbt1395). Nature biotechnology, 42(4), 674. https://doi.org/10.1038/s41587-024-02205-3

@article{52e69f55f7af451aaed4cb86dbae5030,

title = "Correction to: Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors (Nature Biotechnology, (2008), 26, 4, (453-461), 10.1038/nbt1395)",

abstract = "Correction to: Nature Biotechnologyhttps://doi.org/10.1038/nbt1395, published online 30 March 2008. In the version of the article initially published, Supplementary Fig. 10 included duplicated images in the row for day 11. As original data could not be located, a revised Supplementary Fig. 10 is shown in the Supplementary Information accompanying this amendment, with the day 11 row removed.",

author = "Zakrzewski, {Johannes L.} and David Suh and Markley, {John C.} and Smith, {Odette M.} and Christopher King and Goldberg, {Gabrielle L.} and Robert Jenq and Holland, {Amanda M.} and Jeremy Grubin and Javier Cabrera-Perez and Brentjens, {Renier J.} and Lu, {Sydney X.} and Gabrielle Rizzuto and Sant{\textquoteright}Angelo, {Derek B.} and Isabelle Riviere and Michel Sadelain and Glenn Heller and Z{\'u}{\~n}iga-Pfl{\"u}cker, {Juan Carlos} and Chen Lu and {van den Brink}, {Marcel R.M.}",

note = "Publisher Copyright: {\textcopyright} Springer Nature America, Inc. 2024.",

year = "2024",

month = apr,

doi = "10.1038/s41587-024-02205-3",

language = "English (US)",

volume = "42",

pages = "674",

journal = "Nature biotechnology",

issn = "1087-0156",

publisher = "Nature Research",

number = "4",

}

Zakrzewski, JL, Suh, D, Markley, JC, Smith, OM, King, C, Goldberg, GL, Jenq, R, Holland, AM, Grubin, J, Cabrera-Perez, J, Brentjens, RJ, Lu, SX, Rizzuto, G, Sant’Angelo, DB, Riviere, I, Sadelain, M, Heller, G, Zúñiga-Pflücker, JC, Lu, C & van den Brink, MRM 2024, 'Correction to: Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors (Nature Biotechnology, (2008), 26, 4, (453-461), 10.1038/nbt1395)', Nature biotechnology, vol. 42, no. 4, pp. 674. https://doi.org/10.1038/s41587-024-02205-3

TY - JOUR

T1 - Correction to

T2 - Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors (Nature Biotechnology, (2008), 26, 4, (453-461), 10.1038/nbt1395)

AU - Zakrzewski, Johannes L.

AU - Suh, David

AU - Markley, John C.

AU - Smith, Odette M.

AU - King, Christopher

AU - Goldberg, Gabrielle L.

AU - Jenq, Robert

AU - Holland, Amanda M.

AU - Grubin, Jeremy

AU - Cabrera-Perez, Javier

AU - Brentjens, Renier J.

AU - Lu, Sydney X.

AU - Rizzuto, Gabrielle

AU - Sant’Angelo, Derek B.

AU - Riviere, Isabelle

AU - Sadelain, Michel

AU - Heller, Glenn

AU - Zúñiga-Pflücker, Juan Carlos

AU - Lu, Chen

AU - van den Brink, Marcel R.M.

PY - 2024/4

Y1 - 2024/4

N2 - Correction to: Nature Biotechnologyhttps://doi.org/10.1038/nbt1395, published online 30 March 2008. In the version of the article initially published, Supplementary Fig. 10 included duplicated images in the row for day 11. As original data could not be located, a revised Supplementary Fig. 10 is shown in the Supplementary Information accompanying this amendment, with the day 11 row removed.

AB - Correction to: Nature Biotechnologyhttps://doi.org/10.1038/nbt1395, published online 30 March 2008. In the version of the article initially published, Supplementary Fig. 10 included duplicated images in the row for day 11. As original data could not be located, a revised Supplementary Fig. 10 is shown in the Supplementary Information accompanying this amendment, with the day 11 row removed.

UR - http://www.scopus.com/inward/record.url?scp=85188605042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85188605042&partnerID=8YFLogxK

U2 - 10.1038/s41587-024-02205-3

DO - 10.1038/s41587-024-02205-3

M3 - Comment/debate

C2 - 38531977

AN - SCOPUS:85188605042

SN - 1087-0156

VL - 42

SP - 674

JO - Nature biotechnology

JF - Nature biotechnology

IS - 4

ER -

Correction to: Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors (Nature Biotechnology, (2008), 26, 4, (453-461), 10.1038/nbt1395)

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this